Travere Therapeutics TVTX
$ 18.38
0.66%
Quarterly report 2024-Q3
added 10-31-2024
Travere Therapeutics EV/EBITDA Ratio 2011-2024 | TVTX
Annual EV/EBITDA Ratio Travere Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-14.2 | -35.2 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-14.2 | -35.2 | -24.7 |